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activation	 of	 extracellular	 signal-regu-
lated	 kinase,	 a	 signal-transduction	
molecule	 that	 induces	 mitogenesis,	
only	 if	 integrins	were	both	aggregated	
and	 occupied	 by	 FN	 or	 RGD-con-
taining	 peptide	 ligands	 (Miyamoto et 
al.,	 1996).	 These	 findings	 support	 the	
hypothesis	that	GFs	and	integrins	coop-
erate	 in	 a	 coordinate	 fashion	 to	 elicit	
signals	 necessary	 for	 cell	 function,	
especially	mitogenesis.	Because	signal-
transduction	 pathways	 are	 propagated	
along	nanoscale	scaffolding	complexes	
inside	the	cell,	coordinate	GF	and	ECM	
signals	from	the	external	milieu	appar-
ently	require	solid-state	presentation	in	
the	 same	 nanospace;	 otherwise	 their	
resultant	 signal	 transduction	 pathways	
would	be	unable	to	integrate.
Thus,	based	on	this	body	of	 in vitro	
and	 in vivo	 data,	GF–ECM	complexes	
may	 well	 be	 the	 most	 effective	 and	
efficient	method	 to	 stimulate	 cell	 pro-
liferation,	 as	 well	 as	 tissue	 healing	 or	
regeneration,	as	proposed	by	Upton	and	
colleagues	(2008).
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β-Papillomavirus Infection  
and Skin Cancer
Jan	Nico	Bouwes	Bavinck1,	Elsemieke	I.	Plasmeijer2	and		
Mariet	C.	W.	Feltkamp2
The development of highly sensitive PCr techniques and multiplex bead-based 
Luminex platforms has accelerated the search for a specific role of human papil-
loma viruses in the development of squamous cell carcinoma. Human papilloma-
viruses are most likely indirectly involved in this process by facilitating UV-related 
carcinogenesis via preventing UV-induced apoptosis or impairing DnA repair, but 
other mechanisms are also possible.
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It	has	been	widely	accepted	that	human	
papillomavirus	 (HPV)	 16	 and	 related	
HPV	 types	 play	 a	 crucial	 role	 in	 the	
development	 of	 cervical	 and	 anogeni-
tal	carcinomas.	The	 role	of	HPV	 in	 the	
development	 of	 cutaneous	 squamous	
cell	 carcinoma	 (SCC)	 is	 still	 controver-
sial	(Asgari et al.,	2008,	this	issue).
The	 first	 time	 that	 HPV	 infection	
was	 linked	 with	 the	 development	 of	
skin	cancer	was	in	the	rare	genetic	dis-
ease	 epidermodysplasia	 verruciformis	
(EV).	EV	patients	develop	keratotic	skin	
lesions	 that	 display	 a	 high	 rate	 of	 pro-
gression	to	SCC,	mainly	on	sun-exposed	
skin.	They	also	exhibit	diminished	cell-	
mediated	 immunity	 and	 high	 suscepti-
bility	to	infection	with	β-papillomavirus	
(β-PV)	 types	 (formally	 called	 EV-HPV	
types;	Asgari et al.,	2008).
Organ-transplant	 recipients	 (OTRs)	
have	a	greatly	increased	risk	of	develop-
ing	warts	and	other	keratotic	skin	lesions,	
soon	 followed	 by	 the	 development	 of	
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SCC	(Bouwes	Bavinck et al.,	2007).	The	
number	 of	 keratotic	 skin	 lesions	 is	 a	
strong	risk	factor	for	the	development	of	
SCC,	and	the	prevalence	of	β-PV	DNA	
in	precursor	lesions	and	SCC	in	OTRs	is	
close	 to	100%	 (Bouwes	Bavinck et al.,	
2007;	Asgari et al.,	2008).	 In	 immuno-
competent	 individuals,	 the	 prevalence	
of	 HPV	 infection	 is	 lower,	 but	 it	 still	
exceeds	50%	(Asgari et al.,	2008).
In	 this	 issue,	Asgari	 et al.	 present	 a	
study	 of	 immunocompetent	 individu-
als	 (Asgari et al.,	2008).	Using	a	case–	
control	 model	 and	 a	 highly	 sensitive	
nested	 PCR	 technique,	 they	 compared	
lesional,	 perilesional,	 and	 normal	 skin	
of	85	SCC	patients	with	normal	skin	of	
95	 age-	 and	 gender-matched	 individu-
als	without	SCC.	They	confirmed	a	high	
prevalence	 of	 β-PV	DNA	 (49–59%)	 in	
both	 cases	 and	 controls.	DNA	 from	β-
PV	species	2	was	more	often	observed	
in	 SCC	 than	 in	 perilesional	 skin,	 sup-
porting	the	conclusion	that	at	least	some	
β-PV	types	may	be	associated	with	SCC.
In	 this	 commentary	 we	 discuss	 the	
possible	association	between	β-PV	infec-
tion	 and	 SCC,	 because	 this	 PV	 genus	
has	 been	 studied	most	 frequently	with	
respect	 to	 skin	cancer	development.	 In	
the	 future,	 research	may	 also	 focus	 on	
the	 γ-PV	 genus,	 of	 which	 numerous	
new	types	have	recently	been	described	
(Forslund,	2007).
Detection of β-PV infection
β-PV	DNA	detection,	 as	well	 as	detec-
tion	of	other	HPV	types,	employs	molec-
ular	techniques,	and	it	has	evolved	from	
Southern	blotting,	via	dot-blot	analyses,	
to	 highly	 sensitive	 (nested)	 PCR	 meth-
ods.	 Because	 β-PV	 infections	 often	
include	 co-infection	 of	 multiple	 β-PV	
types,	broad-spectrum	PCR	is	used	most	
often	 to	 detect	 β-PV	 infection	 in	 skin.	
PCR	 products	 are	 either	 cloned	 and	
sequenced	(Asgari et al.,	2008)	or	hybrid-
ized	to	β-PV	type-specific	probes	coated	
on	 nitrocellulose	 strips	 or	 arrays.	 The	
clone-and-sequence	approach	has	 limi-
tations	in	the	number	of	clones	analyzed	
and	 therefore	 probably	 underestimates	
the	 number	 of	 β-PV	 types	 included	 in	
a	 co-infection,	 whereas	 line	 blots	 and	
microarrays	 allow	 simultaneous	 detec-
tion	of	up	to	25	β-PV	types	(de	Koning et 
al.,	2006;	Gheit et al.,	2007;	Nindl et al.,	
2007).	The	latter	methods,	however,	have	
the	 disadvantage	 that	 only	 the	 probed	
β-PV	types	are	identified,	and	unknown	
β-PV	or	other	HPV	types	will	be	missed.	
Techniques	 that	 can	 include	 a	 multi-
tude	 of	 cutaneous	 HPV	 probes	 (β-PV,	
γ-PV,	and	others)	are	anticipated,	such	as	
that	found	in	the	new	DNA	microarrays	
and	 the	multiplex	bead-based	 Luminex	
platform	that	is	already	in	use	for	muco-
sal	HPV	type	 identification.	To	estimate	
the	 relative	number	 of	 infected	 cells	 in	
tumors	and	in	healthy	skin	and	hair	sam-
ples,	 quantitative	 real-time	 PCRs	 have	
been	developed	for	frequently	occurring	
β-PV	 types	 (Weissenborn et al.,	 2005).	
Methods	to	detect	β-PV	mRNA,	indicat-
ing	 an	 active	 infection,	 have	 also	 been	
described	 but	 thus	 far	 have	 been	 used	
only	sporadically.
The	 development	 of	 serologic	 tech-
niques	 has	 evolved	 rapidly,	 starting	
with	western	blotting,	followed	by	HPV	
type-specific	 ELISAs	using	 L1	 virus-like	
particles,	 and	 most	 recently	 by	 high-
throughput	multiplex	 fluorescent	 bead-
based	 assays	 (Luminex)	 enabling	 the	
simultaneous	 detection	 of	 antibody	
responses	 in	 large	 series	 of	 serolog-
ic	 samples	 against	 a	 variety	 of	 HPVs	
(Waterboer et al.,	2005).	With	this	meth-
od,	up	to	100	GST-HPV	L1	fusion	pro-
teins	can	be	coupled	to	the	specifically	
colored	beads	and	brought	together	with	
a	small	volume	of	serum.	In	a	relatively	
short	 time,	 the	 Luminex	 platform	 has	
become	 the	 state-of-the-art	method	 for	
large	epidemiologic	studies	into	β-	and	
γ-PV	 humoral	 immune	 responses.	This	
method	 is	 specific,	 reproducible,	 and	
relatively	easy	to	perform.
Thus	far,	it	is	not	known	exactly	what	
drives	 β-PV	 serologic	 responses.	 β-PV	
skin	 infection,	as	 such,	 is	probably	not	
sufficient	to	do	so,	because	the	correla-
tion	with	β-PV	DNA	detection	in	healthy	
skin	or	plucked	hairs	is	poor.	Additional	
“danger”	 signals	 are	 probably	 needed	
to	 prompt	 an	 immune	 response,	 such	
as	might	occur	with	local	inflammation,	
tumor	 growth,	 or	 extensive	 renewal	 or	
proliferation	of	the	skin.
A	 drawback	 of	 the	 advancing	β-PV	
DNA	 detection	 and	 serologic	 tech-
niques	 is	 that	 the	 different	 methods	
preferentially	 detect	 different	 β-PV	
types	 and	 therefore	 the	 different	 stud-
ies	are	not	easily	compared.	The	search	
continues	 for	 a	 system	 by	 which	 all	
HPV	 types	 in	 a	 single	 sample	 can	 be	
easily	and	reliably	detected.
natural history of β-PV infection
The	natural	 history	 of	β-PV	 infection	 is	
largely	 unknown.	 There	 is	 some	 indi-
cation	 that	 it	 occurs	 during	 or	 shortly	
after	birth,	 following	close	contact	with	
infected	 persons,	 such	 as	 parents	 and	
other	family	members.	Whether	(minor)	
wounds	 are	 needed	 to	 transmit	 β-PV,	
as	 is	most	 likely	 the	 case	 for	 common	
wart-causing	HPV	 types,	 is	 not	 known.	
Genetic	 background	 and	 immune	
status	 are	 also	 probably	 important	 fac-
tors	 in	 determining	 the	 outcome	 of	
β-PV	infection.
Hair	bulbs	are	 the	most	 likely	 reser-
voirs	 of	β-PV,	 and	 eyebrow	 hairs	 have	
been	 shown	 to	harbor	 persistent	 infec-
tion	 (Boxman	 et al.,	 1997;	 de	 Koning	
et al.,	2007).	The	exact	 location	of	 this	
virus,	 however,	 has	 never	 been	 stud-
ied	in	depth,	and	the	presence	of	β-PV	
types	 in	 epidermal	 stem	 cells	 cannot	
be	 excluded.	Although	 it	 has	not	 been	
systematically	 studied,	 the	 presence	 of	
β-PV	in	eyebrow	hairs	probably	reflects	
infection	 with	 these	 viruses	 in	 other	
parts	of	the	body.	Using	highly	sensitive	
β-PV	DNA	detection	 techniques,	 it	has	
become	clear	that	β-PV	is	widely	preva-
lent	 in	 plucked	 hairs	 and	 that	 almost	
100%	of	humans	are	infected	(de	Koning 
et al.,	2007).
Increasing	age	is	the	most	important	
factor	 that	 influences	 the	 presence	 of	
β-PV	 DNA	 in	 humans	 (Struijk et al.,	
2003).	 Long-term	 immune	 suppression	
may	also	play	a	role	because	transplant	
recipients	 develop	 numerous	 keratotic	
skin	 lesions	 (Bouwes	 Bavinck et al.,	
2007).	Painful	sunburns	have	also	been	
reported	to	be	associated	with	the	pres-
ence	of	β-PV	DNA,	but	no	 such	asso-
ciation	could	be	observed	with	chronic	
sun	 exposure	 alone	 (Termorshuizen et 
al.,	2004).
β-PV infection and Scc in epidemiologic 
and animal studies
Several	epidemiologic	studies	have	sug-
gested	a	possible	role	for	β-PV	infection	
in	 the	 pathogenesis	 of	 SCC	 (Struijk et 
al.,	2003;	Feltkamp et al.,	2003;	Karagas 
et al.,	 2006;	 Asgari et al.,	 2008).	 The	
association	 of	 keratotic	 skin	 lesions	
with	 SCC	 among	 transplant	 recipients	
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provides	strong	indirect	evidence	of	a	role	
for	β-PV	in	the	etiology	of	SCC	(Bouwes	
Bavinck et al.,	2007).	Plucked	eyebrow	
hairs	 have	 been	 used	 as	 a	 marker	 of	
β-PV	 infection	 in	 cases	 with	 and	 con-
trols	without	SCC.	The	presence	of	β-PV	
DNA	in	these	hairs	has	been	shown	to	
be	associated	with	both	actinic	kerato-
ses	(precursor	lesions	of	SCC)	and	SCC	
(Struijk et al.,	2003).
Other	studies	independently	demon-
strated	an	association	between	serologic	
responses	against	specific	 types	or	spe-
cies	of	β-PV	and	SCC	 (Feltkamp et al.,	
2003;	Karagas et al.,	 2006).	Of	 the	25	
known	 β-PV	 types,	 HPV	 5,	 8,	 15,	 20,	
24,	36,	and	38	have	been	 found	 to	be	
associated	with	SCC,	but	the	studies	per-
formed	so	 far	do	not	consistently	point	
toward	a	single	high-risk	β-PV	type.
All	of	 the	 studies	 so	 far	have	 shown	
that	 the	 quantity	 of	 β-PV	 DNA	 that	 is	
spread	over	the	body	is	very	low—gen-
erally	 the	amount	of	DNA	is	expressed	
as	 one	 copy	 of	β-PV	DNA	 per	n	 cells	
rather	than	as	n	copies	per	cell.
Four	β-PV	 transgenic	mouse	models	
have	been	described.	The	most	 striking	
results	were	 obtained	with	mice	 trans-
genic	for	the	HPV	8	early	region	under	
control	 of	 the	 keratin	 14	 promoter.	
Six	 percent	 of	 these	 backcrossed	mice	
spontaneously	developed	invasive	SCC-
like	lesions	(Schaper et al.,	2005).	HPV	
38	 transgenic	 mice	 that	 expressed	 the	
E6	 and	 E7	 gene	 under	 control	 of	 the	
keratin	10	promoter	did	not	demonstrate	
spontaneous	 outgrowth	 of	 tumors,	 but	
they	did	display	skin	hyperproliferation	
and	 increased	 sensitivity	 to	 chemical	
carcinogens	(Dong et al.,	2005).	Also,	in	
mice	transgenic	for	HPV	20	and	HPV	27	
E6	and	E7	under	control	of	the	K10	pro-
moter,	 signs	 of	 hyperproliferation	were	
seen	 (Michel et al.,	 2006).	 Because	 of	
the	use	of	different	promoters	for	the	β-
PV	transgenes,	it	is	not	possible	to	com-
pare	 the	 findings	 for	HPV	8	with	 those	
for	the	other	β-PV	types.
thoughts on β-PV-related carcinogenesis
The	 high	 prevalence	 of	 β-PV	 infection	
in	humans,	together	with	the	very	small	
amounts	of	β-PV	DNA	in	the	skin,	raises	
the	 question	 of	 how	β-PV	 could	 affect	
the	development	of	SCC.
The	viral	load	in	cancerous	skin	lesions	
seldom	 reaches	 the	 level	 of	 one	 viral	
copy	per	cell	(Weissenborn et al.,	2005),	
indicating	that	β-PVs	are	not	involved	in	
maintenance	of	the	transformed	state	of	
the	 tumor	 cells,	 in	 contrast	 to	 some	 of	
their	genital	counterparts.	Given	that	the	
β-PV	 loads	 in	 actinic	 keratoses	 exceed	
those	found	in	SCC,	β-PV	probably	plays	
a	role	earlier	in	carcinogenesis,	possibly	
through	 a	 “hit-and-run”	 mechanism	 or	
by	facilitating	or	enhancing	carcinogenic	
processes	that	are	initiated	by	sunlight	or	
other	environmental	factors.
It	is	likely	that	short-term	presence	of	
β-PV	DNA	will	not	 increase	the	risk	of	
SCC;	the	virus	probably	must	be	present	
for	a	long	enough	time	and	in	sufficient	
amounts	 to	exert	an	effect.	 It	has	been	
shown	 that	β-PVs	are	persistently	pres-
ent	in	humans	(de	Koning et al.,	2007).	
Conceivably,	 second-degree	 burns	 and	
repetitive	 painful	 sunburns	with	 regen-
eration	of	 the	 skin	 from	 the	underlying	
hair	bulb	could	result	 in	 the	amplifica-
tion	of	β-PV	DNA	via	activation	of	 the	
HPV	life	cycle.	On	the	other	hand,	skin	
diseases	characterized	by	hyperprolifer-
ation	(e.g.,	psoriasis)	could	lead	to	such	
a	viral	replication.
The	interaction	of	β-PV	infection	with	
sunlight	 exposure	 may	 hold	 a	 key	 to	
our	 understanding	 of	 β-PV-related	 car-
cinogenesis.	For	 instance,	UVB	 irradia-
tion	has	been	shown	to	modulate	β-PV-	
promoter	activity	 for	some	 types	of	 the	
virus	 (Akgul et al.,	 2005),	 and	 p53-
responsive	elements	were	found	as	well.	
UV	 exposure	 may	 therefore	 promote	
viral	 transcription	 and	 replication.	 In	
addition,	there	is	evidence	that	the	early	
viral	protein	E6	of	some	β-PV	types	can	
impair	 DNA	 repair	 or	 prevent	 apopto-
sis	 after	 UV	 exposure	 (Leverrier et al.,	
2007).	As	a	result,	β-PV-infected,	DNA-
damaged	cells	may	survive,	with	actinic	
keratoses	 and	 SCC	 as	 final	 outcomes.	
The	latter	observations	would	especially	
fit	 the	idea	that	β-PV	plays	a	role	early	
in	carcinogenesis	and,	ultimately,	when	
UV-induced	 DNA	 damage	 and	 muta-
tions	have	accumulated,	may	be	lost.
Not	 all	 β-PV	 types	 exert	 the	 same	
biologic	 effects.	 Some,	 such	 as	 HPV	
38,	 interact	 with	 pRb,	 whereas	 other	
types	 do	 not.	 HPV	 38	 is	 also	 able	 to	
immortalize	 primary	 keratinocytes,	
although	 not	 as	 efficiently	 as	HPV	 16.	
Immortalization	 by	 HPV	 38	 is	 associ-
ated	with	 slightly	 increased	 telomerase	
activity	 and	 genomic	 instability	 (Gabet 
et al.,	 2008).	 In	 addition,	 functional	
inactivation	 through	 p53	 seems	 con-
fined	 to	 HPV	 38,	 but	 systematic	 stud-
ies	of	 this	aspect	 in	other	PV	 types	are	
not	 yet	 available.	 Preliminary	 results	
from	our	own	group	indicate	that	not	all	
β-PV	types	are	equally	capable	of	abro-
gating	UVB-induced	 apoptosis.	 HPV	 8	
and	HPV	20	are	able	to	do	so,	whereas	
HPV	38	 seems	 incapable	 (unpublished	
observation).	 The	 presence	 of	 different	
β-PV	types	with	different	biologic	effects	
in	the	same	individual	could,	hypotheti-
cally,	augment	the	risk	of	SCC	by	com-
bining	 and	 possibly	 enhancing	 differ-
ent	 biologic	mechanisms.	 It	 cannot	 be	
excluded	that,	beside	β-PV	types,	other	
HPV	 types	 (e.g.,	 γ-PV	 types)	may	 play	
roles	in	the	development	of	SCC.
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Unraveling the Mysteries of IGF-1 
Signaling in Melanoma
John	T.	Lee1,	Patricia	Brafford1	and	Meenhard	Herlyn1
The inherent ability of a cell to undergo apoptosis governs a number of develop-
mental processes essential to proper mammalian development. Into adulthood, 
the pathways that potentiate the apoptotic response are extremely diverse and 
finely regulated to prevent potential diseases. Of these, cancer is often associated 
with loss of an apoptotic response. Hanahan and Weinberg (2000) list evasion of 
apoptosis as a hallmark feature acquired during neoplastic transformation. The 
impact of this event is dramatic on several levels; avoidance of apoptosis not only 
prevents programmed cell death in an array of cell types but also promotes chemo-
therapeutic resistance during anticancer regimens.
Journal of Investigative Dermatology (2008),	128,	1358–1360.	doi:10.1038/jid.2008.124
In	 mammalian	 systems,	 there	 are	 cur-
rently	12	known	members	of	 the	Bcl-2	
family	of	apoptotic	regulators	(Youle	and	
Strasser,	2008);	this	group	is	divided	into	
anti-apoptotic	 members	 (Bcl-2,	 Bcl-XL,	
Mcl-1,	 etc.)	 and	pro-apoptotic	proteins	
(BID,	 BAX,	 BAD,	 NOXA,	 etc.).	 A	 deli-
cate	 balance	 of	 these	 proteins	 dictates	
the	fate	of	a	given	cell;	a	rheostat	exists	
between	 pro-	 and	 anti-apoptotic	 Bcl-2	
family	members	to	modulate	cell	death	
or	survival,	whereby	whichever	is	more	
highly	expressed	determines	the	cellular	
outcome	 (Oltvai	 et al.,	 1993).	 Survivin	
(encoded	by	BIRC5)	is	a	member	of	the	
inhibitors	of	apoptosis	family	of	proteins	
and	functions	similarly	to	anti-apoptotic	
Bcl-2	 family	 members	 (Altieri,	 2008).	
Collectively,	 these	 apoptotic	 proteins	
control	 fundamental	 cell	 fate	decisions	
that	 underlie	 the	 difference	 between	
homeostasis	and	onset	of	disease.
Metastatic	 melanoma	 is	 a	 complex	
malignancy	 that	 is	 refractory	 to	 nearly	
all	known	chemotherapeutics;	as	a	result	
of	the	relative	dearth	of	available	thera-
pies,	the	5-year	survival	rate	for	patients	
afflicted	 with	 metastatic	 melanoma	 is	
approximately	 15%.	The	 inherent	 drug	
resistance	observed	in	melanoma	may	be	
due,	in	part,	to	the	network	of	signaling	
pathways	that	are	activated	during	malig-
nant	 transformation	 (Bennett,	 2008).	
Although	the	cooperative	phenotype	that	
results	from	activation	of	these	pathways	
is	 similar,	 their	 individual	 contributions	
and	overall	 significance	 to	disease	may	
greatly	contrast;	thus,	it	is	paramount	to	
understand	how	each	pathway	can	con-
tribute	to	disease	initiation,	progression,	
and	clinical	manifestation.
The	 IGF-1	 signaling	 axis	 originates	
from	 the	 IGF-1	 receptor.	 IGF-1R	 is	 a	
heterotetramer	 consisting	 of	 two	 extra-
cellular	α	 subunits	 and	 two	β	 subunits	
that	 encompass	 the	 transmembrane	
and	tyrosine	kinase	domains	(Hartog	et 
al.,	2007).	After	ligand	binding,	IGF-1R	
initiates	a	series	of	signaling	events	that	
positively	 affect	 the	 mitogen-activated	
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